Source Financial Advisors’s AbbVie ABBV Stock Holding History

Source Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$400K	Buy	2,028 +2	+0.1%	+$373	0.12%	79
2024 Q2	$347K	Buy	2,026 +28	+1%	+$4.64K	0.11%	85
2024 Q1	$364K	Sell	1,998 -1,256	-39%	-$216K	0.11%	85
2023 Q4	$504K	Sell	3,254 -95	-3%	-$13.8K	0.16%	80
2023 Q3	$499K	Buy	3,349 +164	+5%	+$24.1K	0.17%	73
2023 Q2	$429K	Sell	3,185 -204	-6%	-$29.9K	0.14%	90
2023 Q1	$540K	Sell	3,389 -1,255	-27%	-$192K	0.18%	74
2022 Q4	$751K	Buy	4,644 +74	+2%	+$11.3K	0.28%	61
2022 Q3	$614K	Buy	4,570 +32	+0.7%	+$4.59K	0.24%	66
2022 Q2	$695K	Buy	4,538 +2,803	+162%	+$428K	0.27%	64
2022 Q1	$282K	Sell	1,735 -152	-8%	-$22.1K	0.08%	97
2021 Q4	$256K	Sell	1,887 -134	-7%	-$15.8K	0.07%	98
2021 Q3	$219K	Buy	2,021 +10	+0.5%	+$1.14K	0.06%	101
2021 Q2	$226K	Buy	+2,011	New	+$226K	0.06%	100

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Source Financial Advisors's ABBV Position: Q3 2024 in Review

Source Financial Advisors increased its AbbVie (ABBV) stake by 0.1% in Q3 2024, buying an estimated $373 and bringing the position to 2,028 shares worth $400K. The position accounts for 0.12% of the portfolio, ranked #79.

Source Financial Advisors first reported a position in ABBV in Q2 2021 and has held it in 14 quarters since. The position peaked at $751K in Q4 2022. 3,498 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

Source Financial Advisors held 2,028 shares of AbbVie worth $400K as of Q3 2024.
Source Financial Advisors bought 2 AbbVie shares in Q3 2024, an estimated $373.
AbbVie made up 0.12% of Source Financial Advisors's portfolio in Q3 2024, its #79 holding.
Source Financial Advisors first reported a position in AbbVie in Q2 2021 and has held it in 14 quarters since.
Source Financial Advisors's AbbVie position peaked at $751K in Q4 2022.
3,498 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on Source Financial Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.